Ann: Half Yearly Report and Accounts, page-22

First 22 Last

Share
Profile

Follow
Jalaluddin

1,125 Posts.

173

18/03/19

10:38

Post #: 37794700
Share

Originally posted by beeliney: ↑

I've heard on here that niobium and manganese can be used as substitutes for steel strengthening. Can't say that these are a cheaper or more abundant alternative though.

Yes VFRBs are certainly one leading technology for storage of renewables at a grid level. China is leading the way the demonstrating the scale at which these can be deployed. Next year we should hear news of the completion of a 200MW/800MWh battery I'm Dalian. The world's biggest battery. Will the west go with this or will a virtual battery created by linking up home Li batteries charged with home solar PVs to supply the grid be the front runner? This will obviously be a big determinant in the future of the market for Vanadium. China is the world leader supplying cheap PV systems so why wouldn't they do the same with VFRBs if their deployment is a success and economic.

The low vols traded at this level tends to suggest that we are at at floor here. You've got to acknowledge that the options that have been converted up to Dec last year are around 1/3 of the pre-existing issued capital. You can see new holders from conversion of opps stacking the sell side above 2c looking to get out at break even or a slight profit. This was exacerbated by the risk off sentiment in markets from Oct-Dec last year as yes AVL is a risky and uncertain play.

However, not too many have been willing to part with their newly acquired shares but it can be expected that they will sell into any strength and so I am anticipating a long road to recovery in SP ahead. Any good news like drill results next month to sure up the road to PFS and differentiate between fresh and oxidized layers etc. will most likely be sold into.

Nevertheless, any news of a funding arrangement or a run up again in the Vanadium price should see the sell side evaporate and us moving again up into the 4c region. Patience is the key here! I'd rather be holding rather than listening to the hokey panda and his Japanese named mates who want your cheap shares. Why else would they be talking this down sub the opp conversion price. Patience will be rewarded here if the ducks line up as they should do...

Expand

"AVL is a risky and uncertain play"

One way of "de-risking" AVL is to take a trip to Mt. Newman where vision and capital met.

AVL Price at posting: 1.9¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Chaos reigns markets – so let's take stock of where we're at ahead of December

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 3 more messages in this thread...

First 22 Last

Add AVL (ASX) to my watchlist

(20min delay)
Last 1.4¢		Change 0.001(7.69%)		Mkt cap ! $129.4M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.4¢	$68.23K	4.927M

Buyers (Bids)

No.	Vol.	Price($)
67	29492532	1.3¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	3429220	13

View Market Depth

No.	Vol.	Price($)
20	3787523	0.018
8	2387728	0.017
8	2791875	0.016
11	2263500	0.015
2	500000	0.013

Price($)	Vol.	No.
0.019	862281	2
0.020	404607	6
0.021	598625	6
0.022	1380000	5
0.023	2654010	7

Last trade - 16.10pm 28/11/2024 (20 minute delay)

AVL (ASX) Chart

Ann: Half Yearly Report and Accounts, page-22

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Chaos reigns markets – so let's take stock of where we're at ahead of December

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Buyers (Bids)

Sellers (Offers)